Acinetobacter baumannii genome sequence determined

Italy - The genome sequence of Acinetobacter baumannii has been determined by scientists at the Istituto di Tecnologie Biomediche, the Dipartimento di Malattie Infettive at the Istituto Superiore della Sanità and the Dipartimento di Biologia at Roma Tre University. In Italy alone this antibiotic resistant pathogen causes 4,500 to 7,000 deaths annually.

Genome sequencing is the foundation for rapid diagnosis and targeted therapy approaches, said project manager Gianluca de Bellis. ‘Sequencing was made possible by a further improved technique which can generate more than 100 million DNA bases within a few hours. This translates into a significant time and cost advantage over the previous methods.’ Using this sequencing method the Italian scientists hope to identify new substances for the development of new antibiotics. The phenomenon of antibiotic resistance will be examined from a basic and applied research angle.
This genetic sequence is available free, via www.itb.cnr.it/genome-project.

01.07.2008

More on the subject:

Related articles

Photo

News • Post-injury axon regrowth

Lab-grown model shows ‘irreversible’ spinal cord damage may be reversed

When the spinal cord is damaged, the resulting paralysis is usually considered permanent. Now, a new research approach using lab-grown organoid models suggests that it actually might be reversed.

Photo

News • Focal cortical dysplasia

Lab-grown mini-brains shed light on childhood epilepsy

Why does the same genetic mutation cause FCDII in some patients but not in others? Researchers developed organoids to model a brain malformation responsible for drug-resistant epilepsy in children.

Photo

News • Ependymoma and medulloblastoma tumoroids

New organoids offer deeper insights into pediatric brain cancer

Patient-derived organoids (PDOs), or tumoroids, for pediatric brain cancer show promise in helping researchers find new drugs and better understand the different responses of the tumor.

Subscribe to Newsletter